Rebecca Buckalew
Nurse Practitioner · Montgomery, ALNPI 1649635079
Payments from drug & device makers
Across 120 payments — averaging $18.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$355
- Boehringer Ingelheim$255
- Pfizer$254
- AbbVie$252
- GSK$200
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$120
- plus $789 from 19 others
What the payments were for
- Food & beverage$2,01190%
- Education$21310%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 11 | $355 |
| Boehringer Ingelheim | 17 | $255 |
| Pfizer | 15 | $254 |
| AbbVie | 14 | $252 |
| GSK | 10 | $200 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $120 |
| Amarin Pharma, Inc. | 6 | $95 |
| Novo Nordisk | 5 | $84 |
| Intuitive Surgical | 1 | $77 |
| Lilly USA, LLC | 4 | $71 |
| IBSA Pharma Inc. | 4 | $68 |
| Ironwood Pharmaceuticals, Inc | 4 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
| Johnson & Johnson | 3 | $50 |
| Baudax Bio Inc. | 1 | $47 |
| Daiichi Sankyo Inc. | 2 | $32 |
| Nestle Healthcare Nutrition Inc. | 2 | $30 |
| Abbott | 2 | $24 |
| Exact Sciences | 1 | $15 |
| Amgen | 1 | $15 |
| Inogen, Inc. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| Merck | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Xeris Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$2,224 in reported general payments places this provider in the 80th percentile of 1,505 nurse practitioner providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 87 | $89,674 |
| JardianceEmpagliflozin | 55 | $59,442 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 60 | $56,831 |
| EliquisApixaban | 38 | $31,101 |
| JanuviaSitagliptin Phosphate | 15 | $24,361 |
| TrulicityDulaglutide | 16 | $18,874 |
| LinzessLinaclotide | 13 | $12,203 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 15 | $9,700 |
| Incruse ElliptaUmeclidinium Bromide | 12 | $4,531 |
| Ezetimibe | 101 | $3,063 |
| Atorvastatin Calcium | 213 | $2,937 |
| Losartan Potassium | 192 | $2,623 |
| Amlodipine Besylate | 213 | $1,755 |
| Omeprazole | 93 | $1,743 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 75 | $1,709 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $71 | $108,548103 claims |
| GSKTrelegy Ellipta, Incruse Ellipta | $200 | $61,36272 claims |
| Boehringer IngelheimJardiance | $255 | $59,44255 claims |
| MerckJanuvia, Janumet Xr | $14 | $34,06130 claims |
| PfizerEliquis | $254 | $31,10138 claims |
| AbbVieLinzess, Synthroid | $252 | $13,33727 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,505 nurse practitioner providers in Alabama.
Other nurse practitioner in Montgomery
- Audrey MorganMontgomery$24K
- Ashley HodgensMontgomery$19K
- Kellie BagiMontgomery$14K
- Jessica AdairMontgomery$14K
- Taylor LemkeMontgomery$9K
- Joanne MackinMontgomery$8K
- Kristi SpringerMontgomery$8K
- Erin TannerAlabaster$141K
- Ardie Pack MabienMobile$126K
- Ginger McDanielBirmingham$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.